Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JOEL ADAM WEINTHAL

Allopathic & Osteopathic Physicians Pediatrics Pediatric Hematology-Oncology

NPI
1669415535
CMS profile
166336
Location
DALLAS, TX

General Payments · PY2018–2021

$225,076.22

  • Reported across 245 records
  • CMS publication 2026-01-23

Latest program year · PY2021

$47,984.83

33 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2021 · sorted by reported total

By paying entity

PY2021 · sorted by reported total

Paying entityAmountRecords
GENZYME CORPORATION $23,072.25 15
Takeda Pharmaceuticals U.S.A., Inc. $12,497.00 9
Amgen Inc. $12,381.06 8
SEAGEN INC. $34.52 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $64,395.97 89
PY2019 $77,644.00 89
PY2020 $35,051.42 34
PY2021 $47,984.83 33

Payment records · PY2021 (33)

Sorted by paying entity, then date · as published by CMS

Program year 2021 201820192020 Record-level detail is published for PY2021; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $2,250.00 05/05/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 825424037 CMS
Amgen Inc. $2,250.00 06/04/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 825424043 CMS
Amgen Inc. $118.56 06/23/2021 Food and Beverage Undisputed 01/23/2026 825424067 CMS
Amgen Inc. $2,250.00 06/24/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 825424049 CMS
Amgen Inc. $1,687.50 07/21/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 825424055 CMS
Amgen Inc. $2,250.00 08/17/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 825424061 CMS
Amgen Inc. $787.50 11/05/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 825424073 CMS
Amgen Inc. $787.50 11/24/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 825424079 CMS
GENZYME CORPORATION $908.00 01/20/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 843462893 CMS
GENZYME CORPORATION $1,589.00 03/02/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 843462857 CMS
GENZYME CORPORATION $4,067.00 03/22/2021 Consulting Fee Undisputed 01/23/2026 843462873 CMS
GENZYME CORPORATION $525.00 05/11/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 843462871 CMS
GENZYME CORPORATION $1,589.00 07/20/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 843462883 CMS
GENZYME CORPORATION $1,589.00 08/31/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 860884053 CMS
GENZYME CORPORATION $2,420.00 09/13/2021 Consulting Fee Undisputed 01/23/2026 843462895 CMS
GENZYME CORPORATION $1,589.00 09/21/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 843462891 CMS
GENZYME CORPORATION $1,589.00 09/30/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 843462889 CMS
GENZYME CORPORATION $4,767.00 11/10/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 843462899 CMS
GENZYME CORPORATION $615.51 11/10/2021 Travel and Lodging Undisputed 01/23/2026 843462901 CMS
GENZYME CORPORATION $4.50 11/10/2021 Travel and Lodging Undisputed 01/23/2026 843462903 CMS
GENZYME CORPORATION $106.95 11/10/2021 Travel and Lodging Undisputed 01/23/2026 843462905 CMS
GENZYME CORPORATION $124.29 11/10/2021 Food and Beverage Undisputed 01/23/2026 843462907 CMS
GENZYME CORPORATION $1,589.00 12/02/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 860884057 CMS
Seagen Inc. $34.52 08/25/2021 Food and Beverage Undisputed 01/23/2026 832184367 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,125.00 01/20/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 820330921 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,125.00 02/03/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 820330925 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,125.00 04/06/2021 Consulting Fee Undisputed 01/23/2026 820330929 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,125.00 04/08/2021 Consulting Fee Undisputed 01/23/2026 820330933 CMS
Takeda Pharmaceuticals U.S.A., Inc. $3,250.00 05/03/2021 Consulting Fee Undisputed 01/23/2026 820330937 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,702.00 06/30/2021 Consulting Fee Undisputed 01/23/2026 820330941 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,350.00 10/24/2021 Consulting Fee Undisputed 01/23/2026 820330945 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,350.00 10/25/2021 Consulting Fee Undisputed 01/23/2026 820330949 CMS
Takeda Pharmaceuticals U.S.A., Inc. $345.00 10/27/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 820330953 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021
Generated from
OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.